LEADER 05449nam  2200625Ia 450 
001 9910960392903321
005 20251116181441.0
010   $a1-61942-869-5
035   $a(CKB)2550000001040691
035   $a(EBL)3017873
035   $a(SSID)ssj0000918868
035   $a(PQKBManifestationID)12343231
035   $a(PQKBTitleCode)TC0000918868
035   $a(PQKBWorkID)10908813
035   $a(PQKB)11540774
035   $a(MiAaPQ)EBC3017873
035   $a(Au-PeEL)EBL3017873
035   $a(CaPaEBR)ebr10654844
035   $a(OCoLC)923654006
035   $a(BIP)37652814
035   $a(EXLCZ)992550000001040691
100   $a20111102d2012      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aAtaxia $ecauses, symptoms and treatment /$fSung Hoi Hong, editor
205   $a1st ed.
210   $aNew York $cNova Science Publishers$dc2012
215   $a1 online resource (213 p.)
225 0 $aNeuroscience research progress
300   $aDescription based upon print version of record.
311 08$a1-61942-867-9 
320   $aIncludes bibliographical references and index.
327   $a""ATAXIA ""; ""ATAXIA ""; ""CONTENTS ""; ""PREFACE ""; ""ROLE OF THE ATAXIA TELANGIECTASIA MUTATED PROTEIN IN STRESS-INDUCED  PREMATURE SENESCENCE ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""ATM ACTIVATION ""; ""ATM SUBSTRATES ""; ""P53 STRUCTURE, ACTIVATION AND FUNCTION ""; ""ROLES OF ATM AND P53 IN DNA REPAIR""; ""MULTIPLE FUNCTIONS OF P21 IN THE ATM NETWORK ""; ""SEQUENTIAL WAVES OF P53 ACTIVATION BY DNA DAMAGE ""; ""ATM-DEPENDENT SENESCENCE ""; ""ATM-INDEPENDENT SENESCENCE ""; ""ROLE OF ATM IN PREVENTING ESCAPE FROM SIPS: A NOVEL TUMOR SUPPRESSOR FUNCTION BEYOND P53? ""
327   $a""POTENTIAL THERAPEUTIC APPROACHES FOR THE  TREATMENT OF AT """"CONCLUSION""; ""ACKNOWLEDGMENTS ""; ""REFERENCES""; ""ATAXIA TELANGIECTASIA: MOLECULAR BASIS, DIAGNOSIS AND TREATMENT ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""CLINICAL FEATURES OF A-T ""; ""Neurological Phenotype and Cutaneous Manifestations ""; ""Immunodeficiency and Pulmonary Complications ""; ""Predisposition to Cancer and Chromosomal Instability""; ""Endocrine Dysfunction ""; ""PATHOGENESIS AND MOLECULAR DEFECT ""; ""ATM and Neurodegeneration""; ""ATM and Oxidative Stress ""; ""DIAGNOSIS AND TREATMENT ""; ""CONCLUSION ""
327   $a""REFERENCES """"THE NEUROBIOLOGY OF EPISODIC ATAXIA TYPE 1, A SHAKER-LIKE K+ CHANNEL DISORDER ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""STRUCTURE AND FUNCTION OF SHAKER-LIKE K+ CHANNELS ""; ""PHYSIOLOGICAL ROLE OF KV CHANNELS ""; ""Hippocampus ""; ""Cerebellum ""; ""Sciatic Nerve ""; ""BIOTECHNOLOGY FOR STUDYING ION CHANNELS ""; ""EPISODIC ATAXIA TYPE 1: ""; ""Clinical Findings ""; ""Genetic Causes ""; ""Molecular Pathogenetic Mechanisms Underlying EA1""; ""Animal Models of EA1""; ""Treatment of EA1 ""; ""BRIEF OVERVIEW OF RELATED ATAXIA DISORDERS ""; ""CONCLUSION ""; ""ACKNOWLEDGMENTS ""
327   $a""REFERENCES """"MITOCHONDRIAL ATAXIAS ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""ATAXIA IN MITOCHONDRIAL DISORDERS ""; ""MtDNA Point Mutations ""; ""MtDNA Sporadic Rearrangements ""; ""Infantile Onset Spinocerebellar Ataxia ""; ""POLG1-Related Diseases ""; ""OPA1-Related Diseases ""; ""Coenzyme Q10 Deficiency ""; ""FRIEDREICH ATAXIA ""; ""Mitochondrial Therapies for Friedreich Ataxia ""; ""MITOCHONDRIA AND OTHER GENETIC ATAXIAS ""; ""Dominant Spino-Cerebellar Ataxias ""; ""X-Linked Ataxias ""; ""CONCLUSION ""; ""REFERENCES ""
327   $a""EPIDEMIC SEASONAL ATAXIC SYNDROME: EPIDEMIOLOGY, CLINICAL PRESENTATION, ETIOLOGICAL MECHANISMS AND THERAPY   """"ABSTRACT ""; ""INTRODUCTION ""; ""ETIOLOGY ""; ""Viral Hypothesis ""; ""Toxins in Food""; ""Hypothesis of Thiamine Deficiency ""; ""CLINICAL PRESENTATION OF SAS IS COMPATIBLE WITH WERNICKEa???S ENCEPHALOPATHY ""; ""MECHANISM OF THIAMINE DEFICIENCY  IN SEASONAL ATAXIC SYNDROME ""; ""THERAPY AND CONTROL OF SAS ""; ""REFERENCES ""; ""CLINICAL AND GENETIC ASPECTS OF RECESSIVE ATAXIAS ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""THE DEGENERATIVE ATAXIAS ""; ""Friedreicha???s Ataxia ""
327   $a""Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) ""
330   $aAtaxia is a neurological sign and symptom characterised by lack of co-ordination of muscle movement that is due to dysfunction of the parts of the nervous system, such as motor control of the cerebellum. Although the cause of the dysfunction varies from mutations in channels for potassium and/or calcium to progressive degeneration of cerebellar tissue-specific neurons, the neurological signs and symptoms of ataxia are similar. The treatment of ataxia and its effectiveness depend on the underlying cause, and it could be managed by pharmacological treatments and through physical therapy and occupational therapy. The treatment may ameliorate the signs of ataxia, but it is not likely to eliminate them entirely. In this book, the authors present current research in the study of the causes, symptoms and treatments on ataxia.
410  0$aNeuroscience Research Progress
606   $aAtaxia
606   $aMovement disorders
615  0$aAtaxia.
615  0$aMovement disorders.
701   $aHong$b Sung Hoi$01863471
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910960392903321
996   $aAtaxia$94470120
997   $aUNINA